Related Experiment Video
Updated: Mar 6, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Rare non-tuberculous mycobacterial infection following hyaluronic acid injection
Amina Dokara1, Anne Torunn Mengshoel2, Hedda von der Lippe3
1Øre-nese-hals-avdelingen, Lovisenberg diakonale sykehus, og, Akershus universitetssykehus.
Background:
Non-tuberculous mycobacterial (NTM) infections are an emerging complication of injection treatments and may lead to delayed diagnosis when routine cultures are insufficient.
Case Presentation:
We present a case of a woman in her 50s with a chronic ulcerative lesion following hyaluronic acid injections administered abroad. Her history included prior nasal trauma and a silicone implant. Initial empirical treatment and repeated routine cultures were unsuccessful. Only after extended aerobic and anaerobic incubation and referral for molecular analysis were Mycobacterium wolinskyi, a rare rapidly growing NTM, together with Cutibacterium acnes identified. The patient was successfully treated with a 14-week course of ciprofloxacin and doxycycline alongside implant removal.
Interpretation:
This case underscores the importance of providing thorough clinical information on microbiology requisitions, especially in suspected foreign body infections or after injection treatments, and the need for heightened awareness of NTM infections.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

